Kenneth A. Foon - Concepedia

Author

Kenneth A. Foon

Also Known As

Foon, Kenneth A., K A Foon, K Foon, K. A. FOON, K. A. Foon, K. Foon, K.A Foon, K.A. FOON, KENNETH A. FOON, Kenneth A Foon

257

Publications

13.9K

Citations

H-Index

100

Concepts

All Affiliations

UPMC Hillman Cancer Center Markey Cancer Center University of Cincinnati National Cancer Institute National Institutes of Health

About

Kenneth A. Foon is an author at UPMC Hillman Cancer Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	68	4K
2	Health Sciences	10	11	1K
3	Allergy	6	6	205
4	Engineering	1	1	64
5	Biochemistry	1	1	73

Kenneth A. Foon

114

Publications

12K

Citations

H-Index

Page 1

	Year	Citations
Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. Roy A. Patchell, Phillip A. Tibbs, William F. Regine, PubMed	1998	1.9K
IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma David G. Maloney, Antonio J Grillo-López, Christine A. White, Blood	1997	1.7K
Immunologic classification of leukemia and lymphoma. Kenneth A. Foon, Robert F. Todd PubMed	1986	751
Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Robert W. Schroff, Kenneth A. Foon, Shannon M. Beatty, PubMed ImmunohematologyImmunocytochemical TechniqueImmunologyImmunodominanceImmunotherapeutics	1985	491
Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy C. Darrell Jennings, Kenneth A. Foon Blood	1997	455
Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group Bruce D. Cheson, John M. Bennett, R. Kanti, American Journal of Hematology	1988	407
Safety, Pharmacokinetics, and Activity of ABX-EGF, a Fully Human Anti–Epidermal Growth Factor Receptor Monoclonal Antibody in Patients With Metastatic Renal Cell Cancer Eric K. Rowinsky, Garry Schwartz, Jared Gollob, Journal of Clinical Oncology	2004	323
Increased Frequency and Suppression by Regulatory T Cells in Patients with Acute Myelogenous Leukemia Mirosław J. Szczepański, Marta Szajnik, Malgorzata Czystowska, Clinical Cancer Research	2009	294
Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a Interferon Kenneth A. Foon, Stephen A. Sherwin, Paul G. Abrams, New England Journal of Medicine	1984	278
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients Anthony R. Mato, Brian T. Hill, Nicole Lamanna, Annals of Oncology Hematological MalignancyLymphoid NeoplasiaOptimal SequencingChronic Lymphocytic LeukemiaMedicine	2017	219

Page 1